Beta3-adrenoreceptors in cardiovasular diseases: New roles for an "old" receptor

Current Drug Delivery

Volumn 10, Issue 1, 2013, Pages 64-66

  Balligand, Jean Luc ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Beta3 adrenergic receptor; Catecholamines; Heart failure; Human; Hypertrophy; Myocardial remodeling; Nitric oxide

Indexed keywords

4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; ENDOTHELIUM DERIVED RELAXING FACTOR; NEBIVOLOL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADRENERGIC STIMULATION; ANGIOGENESIS; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; ENDOTHELIUM CELL; FIBROBLAST; HEART FAILURE; HEART HYPERTROPHY; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART STRESS; HUMAN; MUSCLE FIBER MEMBRANE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; VASODILATATION;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; MYOCARDIUM; RECEPTORS, ADRENERGIC, BETA-3;

EID: 84875286248     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/1567201811310010011     Document Type: Article

References (16)

1. Dessy, C.; Balligand, J.L. Beta3-adrenergic receptors in cardiac and vascular tissues emerging concepts and therapeutic perspectives. Adv. Pharmacol., 2010, 59,135-163.
2. Moniotte, S.; Kobzik, L.; Feron, O.; Trochu, J.N.; Gauthier, C.; Balligand, J.L. Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation, 2001, 103, 1649-1655.
3. Dessy, C.; Saliez, J.; Ghisdal, P.; Daneau, G.; Lobysheva, I.I.; Frerart, F.; Belge, C.; Jnaoui, K.; Noirhomme, P.; Feron, O.; Balligand, J.L. Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol. Circulation, 2005, 112, 1198-1205.
4. Moniotte, S.; Vaerman, J.L.; Kockx, M.M.; Larrouy, D.; Langin, D.; Noirhomme, P.; Balligand, J.L. Real-time RT-PCR for the detection of beta-adrenoceptor messenger RNAs in small human endomyocardial biopsies. J. Mol. Cell. Cardiol., 2001, 33, 2121-2133.
5. Balligand, J.L.; Hammond, J. Protein kinase G type I in cardiac myocytes: unmasked at last? Eur. Heart. J., 2011, December 23.
6. Dessy, C.; Moniotte, S.; Ghisdal, P.; Havaux, X.; Noirhomme, P.; Balligand, J.L. Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization. Circulation, 2004, 110, 948-954.
7. Balligand, J.L. Beta(3)-Adrenoceptor stimulation on top of beta(1)-adrenoceptor blockade Stop or Encore?. J. Am. Coll.Cardiol., 2009, 53, 1539-1542.
8. Aragon, J.P.; Condit, M.E.; Bhushan, S.; Predmore, B.L.; Patel, S.S.; Grinsfelder, D.B.; Gundewar, S.; Jha, S.; Calvert, J.W.; Barouch, L.A.; Lavu, M.; Wright, H.M.; Lefer, D.J. Beta3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation. J. Am. Coll. Cardiol., 2011, 58, 2683-2691.
9. Calvert, J.W.; Condit, M.E.; Aragon, J.P.; Nicholson, C.K.; Moody, B.F.; Hood, R.L.; Sindler, A.L.; Gundewar, S.; Seals, D.R.; Barouch, L.A.; Lefer, D.J. Exercise protects against myocardial ischemia-reperfusion injury via stimulation of beta(3)-adrenergic receptors and increased nitric oxide signaling: role of nitrite and nitrosothiols. Circ. Res., 2011,108, 1448-1458.
10. Gauthier, C.; Leblais, V.; Kobzik, L.; Trochu, J.N.; Khandoudi, N.; Bril, A.; Balligand, J.L.; Le, M.H. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J. Clin. Invest., 1998, 102, 1377-1384.
11. Hammond, J.; Balligand, J.L. Nitric oxide synthase and cyclic GMP signaling in cardiac myocytes: from contractility to remodeling. J. Mol. Cell Cardiol., 2012, 52, 330-340.
12. Sorrentino, S.A.; Doerries, C.; Manes, C.; Speer, T.; Dessy, C.; Lobysheva, I.; Mohmand, W.; Akbar, R.; Bahlmann, F.; Besler, C.; Schaefer, A.; Hilfiker-Kleiner, D.; Luscher, T.F.; Balligand, J.L.; Drexler, H.; Landmesser, U. Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells, myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional beta1-blockade. J. Am. Coll. Cardiol., 2011, 57, 601-611.
13. Niu, X.; Watts, V.L.; Cingolani, O.H., Sivakumaran, V.; Leyton-Mange, J.S.; Ellis, C.L.; Miller, K.L.; Vandegaer, K.; Bedja, D.; Gabrielson, K.L.; Paolocci, N.; Kass, D.A.; Barouch, L.A. Cardioprotective effect of Beta-3 adrenergic receptor agonism: role of neuronal nitric oxide synthase. J. Am. Coll. Cardiol., 2012, 59, 1979-1987.
14. Gauthier, C.; Rozec, B.; Manoury, B.; Balligand, J.L. Beta-3 adrenoceptors as new therapeutic targets for cardiovascular pathologies. Curr. Heart Fail Rep., 2011, 8, 184-192.
15. Flather, M.D.; Shibata, M.C.; Coats, A.J.; van Veldhuisen, D.J.; Parkhomenko, A.; Borbola, J.; Cohen-Solal, A.; Dumitrascu, D.; Ferrari, R.; Lechat, P.; Soler-Soler, J.; Tavazzi, L.; Spinarova, L.; Toman, J.; Bohm, M.; Anker, S.D.; Thompson, S.G.; Poole-Wilson, P.A. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur. Heart J, 2005, 26, 215-225.
16. Bundgaard, H.; Liu, C.C.; Garcia, A.; Hamilton, E.J.; Huang, Y.; Chia, K.K.; Hunyor, S.N.; Figtree, G.A.; Rasmussen, H.H. Beta(3) adrenergic stimulation of the cardiac Na+-K+ pump by reversal of an inhibitory oxidative modification. Circulation, 2010, 122, 2699-2708.